Larry Yost

Am currently General Manager for IntegraGen, Inc., a Cambridge, Massachusetts based subsidiary of the biomarker discovery/molecular diagnostic/genomic services company IntegraGen SA which is based in France. Responsibilities include overall management of the Company's U.S. operations and leadership for business development and commercialization activities associated with the company's proprietary molecular diagnostic tests.

The mission of The Atticus Group, LLC is to partner with medical technology and molecular diagnostic companies in the development strategic plans and tactical marketing initiatives which drive revenue growth helping them to achieve their business objectives. The Atticus Group’s primary focus is towards companies which have novel medical technologies being commercialized in the U.S. and select global markets.

Led commercialization of Salient Surgical’s products and all associated marketing activities with a focus on orthopedic reconstructive surgery, instrumented spine, and surgical oncology markets. Responsibility for marketing team hiring and development.

Led all marketing initiatives associated with the commercialization of the LifeSite® Hemodialysis Access System, a unique new class of vascular access technology for dialysis patients. Built and provided leadership to a Marketing Department responsible for implementing promotional, educational and public relation strategies designed to support the successful commercialization of the LifeSite System.

Senior Manager, Marketing, Renal Division, Baxter Japan Ltd. (1999 to 200) - Facilitated cross-functional strategic planning between Japanese Product Marketing, Therapy Development & Marketing Communications Groups to insure alignment of activities. Senior Manager, Global Marketing, Renal Division (1996 to 1999) - Supported development of promotional & educational programs that advanced scientific understanding of improved outcomes related to practice of peritoneal dialysis on a global basis.